Skip to main content
    K

    Keros Therapeutics Inc (KROS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $11.31
    +1.28 (+12.76%)

    Market Cap: $196.83M

    Last updated: Nov 17, 2026 at 4:34 PM ET

    Keros Therapeutics Inc (KROS) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Keros Therapeutics (KROS) has a latest price of $11.31 on Nov 17, 2026, 49.8% below its 52-week high of $22.55. Its price fell 34.5% over the past 12 months. The month-end price fell 73.5% over the 5 years through Oct 2026, a compound annual decline of 23.3%.

    Price Chart

    From Apr 2020 to Oct 2026, its highest month-end close was $75.61 in Nov 2020 and its lowest $10.07 in Jul 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart KROS with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for KROS.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 1.9%, and over 6 months it rose 14.1%. The month-end price fell 61.3% over the 3 years through Oct 2026, a compound annual decline of 27.1%.

    PeriodChange
    1 month+2.3%
    3 months+1.9%
    6 months+14.1%
    12 months-34.5%
    12 months, with dividends-34.5%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-61.3%-27.1%
    5 years-73.5%-23.3%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 28.6%, and its weakest was 2024, when it fell 60.2%.

    YearCloseChange
    2026 through Oct 2026$11.04-45.8%
    2025$20.36+28.6%
    2024$15.83-60.2%
    2023$39.76-17.2%
    2022$48.02-17.9%
    2021$58.51-17.1%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 2.7% above its 50-day average of $11.01 and 2.1% below its 200-day average of $11.55.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$11.31
    52-week high$22.55-49.8%
    52-week low$8.98+25.9%
    50-day average$11.01+2.7%
    200-day average$11.55-2.1%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 87.0%.

    MeasureValue
    1-year beta1.19
    Largest fall, 1 year-58.0%
    Largest fall, 3 years-87.0%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About KROS

    What is KROS's 1-year price change?

    Keros Therapeutics's price fell 34.5% over the past 12 months. With dividends included, the 12-month total return was -34.5%.

    What is KROS's 5-year price change?

    Keros Therapeutics's month-end price fell 73.5% over the 5 years through Oct 2026, a compound annual decline of 23.3%. These figures leave out dividends.

    What is KROS's 52-week high and low?

    Keros Therapeutics's 52-week high is $22.55 and its 52-week low is $8.98. Its latest price of $11.31 on Nov 17, 2026 is 49.8% below the high.

    What is KROS's beta?

    Keros Therapeutics's 1-year beta against the S&P 500 is 1.19, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 58.0%.

    Is the KROS chart free?

    Yes. Advanced Charting for KROS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.